Repligen Corporation (RGEN)
After hours:
| Previous close | 144.49 |
| Open | 144.72 |
| Bid | 146.45 x 200 |
| Ask | 147.20 x 300 |
| Day's range | 143.01 - 147.02 |
| 52-week range | 110.45 - 211.13 |
| Volume | |
| Avg. volume | 935,183 |
| Market cap | 8.216B |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.03 |
| Earnings date | 29 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 192.07 |
Insider MonkeySeveral Headwinds Dragged Repligen Corporation (RGEN) in Q2
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its second quarter 2024 investor letter. A copy of the fund can be downloaded here. In the quarter, the fund returned -6.01%, while the benchmark, the Russell 2500 Growth Index, returned -4.22%. The second quarter brought a significant change in market sentiment. The underperformance of […]
- Insider Monkey
Reasons for the Decline of Repligen (RGEN) in Q2
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The Small Company Fund returned -6.57%, underperforming the Russell 2000 Growth index’s 2.92% decline. Fundamental and macroeconomic factors drove the underperformance of the fund in […]
- Insider Monkey
Repligen Corporation (RGEN) Fell Due to CEO Transition
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the Fund (Investor Shares) declined -5.80% (net of fees) underperforming the Russell Midcap Index’s -3.35% return. Stock selection drove the underperformance of the portfolio. The […]
